Detection of cancer-associated antigen(s) in urine of sarcoma patients
β Scribed by Rishab K. Gupta; Donald L. Morton
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 542 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Tumor-associated antigens were demonstrated in concentrated and dialyzed urine of several sarcoma patients with large tumor burden. The antigens were detected by complement fixation using autologous and allogeneic sera from sarcoma patients. The antigenic activity in three patients who were studied sequentially disappeared after surgical ablation of tumor. In two of these three patients, the antigenic activity reappeared before tumor recurrence. The reactivity of the sarcoma sera t o the urine could be abolished by absorption of the sera with human sarcoma cells but not by normal human liver cells, which indicates that the same antigen was present in the urine and o n biopsy-obtained sarcoma cells. Urine from cancer patients with high tumor burden may be useful as a source of tumor-associated antigen. Further studies o n the presence of these antigens in urine of sarcoma patients may lead t o a method for detecting subclinical tumor recurrence.
.......
π SIMILAR VOLUMES
A radioimmunoassay (RIA) test for human pancreatic cancer-associated antigen (Span-I) was developed to evaluate the diagnosis of various gastrointestinal disorders. Serum Span-1 in normal subjects ranged from 5 to 275 lJ/ml, with a mean of 58.8 U/ml (k58.7, standard deviation). All control subjects
## Abstract Urine samples collected from patients with colon carcinoma and from normal donors were tested for antigenic activity by the microcomplement fixation assay. When autologous serum was used as the antibody source, 65.4% (17/26) of the urine samples from patients with colon carcinoma were p
## Abstract Previous publications from our laboratory have demonstrated the presence of antigens in the urine of cancer patients detectable by the complement fixation (CF) assay. The purpose of this study was to develop a methodology for purification of these tumorβassociated antigen(s) using xenog
## Abstract Epidemiological studies indicate that acquired immunodeficiency syndrome (AIDS)βassociated Kaposi's sarcoma (KS) may be caused by an infectious, preferentially sexually transmitted agent. Infections with human papilloma viruses are common, sexually transmitted diseases occurring frequen
The urine of 68% of melanoma patients contains a high molecular weight glycoprotein which is expressed by melanoma cells and reacts with autologous antibody. Since high levels of this antigen in urine correlate with disease recurrence in surgically treated melanoma patients, it has been termed urina